+1 347 708 0418
This report studies the T-Cell Immunotherapy market, covering market size for segment by type (CAR-T, TCR, etc.), by application (Hematologic Malignancies, Solid Tumors, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AbbVie, Adaptimmune, Altor Bioscience, Amgen, Bluebird Bio, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for T-Cell Immunotherapy from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the T-Cell Immunotherapy market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of T-Cell Immunotherapy including:
AbbVie
Adaptimmune
Altor Bioscience
Amgen
Bluebird Bio
Celgene Corporation
Cellectis
DiaCarta
Fate Therapeutics
Gilead Sciences
Juno Therapeutics
Kite Pharma
Merck
Novartis
Pfizer
Sorrento Therapeutics
Takara Bio
TCR2 Therapeutics
Unum Therapeutics
Market split by Type, can be divided into:
CAR-T
TCR
TIL Therapies
Market split by Application, can be divided into:
Hematologic Malignancies
Solid Tumors
Others
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Table of Contents
Chapter 1 T-Cell Immunotherapy Market Overview
1.1 T-Cell Immunotherapy Definition
1.2 Global T-Cell Immunotherapy Market Size Status and Outlook (2016-2030)
1.3 Global T-Cell Immunotherapy Market Size Comparison by Region (2016-2030)
1.4 Global T-Cell Immunotherapy Market Size Comparison by Type (2016-2030)
1.5 Global T-Cell Immunotherapy Market Size Comparison by Application (2016-2030)
1.6 Global T-Cell Immunotherapy Market Size Comparison by Sales Channel (2016-2030)
1.7 T-Cell Immunotherapy Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 T-Cell Immunotherapy Market Segment Analysis by Player
2.1 Global T-Cell Immunotherapy Sales and Market Share by Player (2019-2021)
2.2 Global T-Cell Immunotherapy Revenue and Market Share by Player (2019-2021)
2.3 Global T-Cell Immunotherapy Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 T-Cell Immunotherapy Market Segment Analysis by Type
3.1 Global T-Cell Immunotherapy Market by Type
3.1.1 CAR-T
3.1.2 TCR
3.1.3 TIL Therapies
3.2 Global T-Cell Immunotherapy Sales and Market Share by Type (2016-2021)
3.3 Global T-Cell Immunotherapy Revenue and Market Share by Type (2016-2021)
3.4 Global T-Cell Immunotherapy Average Price by Type (2016-2021)
3.5 Leading Players of T-Cell Immunotherapy by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 T-Cell Immunotherapy Market Segment Analysis by Application
4.1 Global T-Cell Immunotherapy Market by Application
4.1.1 Hematologic Malignancies
4.1.2 Solid Tumors
4.1.3 Others
4.2 Global T-Cell Immunotherapy Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of T-Cell Immunotherapy by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 T-Cell Immunotherapy Market Segment Analysis by Sales Channel
5.1 Global T-Cell Immunotherapy Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global T-Cell Immunotherapy Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of T-Cell Immunotherapy by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 T-Cell Immunotherapy Market Segment Analysis by Region
6.1 Global T-Cell Immunotherapy Market Size and CAGR by Region (2016-2030)
6.2 Global T-Cell Immunotherapy Sales and Market Share by Region (2016-2021)
6.3 Global T-Cell Immunotherapy Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America T-Cell Immunotherapy Market Share by Type
6.4.3 North America T-Cell Immunotherapy Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe T-Cell Immunotherapy Market Share by Type
6.5.3 Europe T-Cell Immunotherapy Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific T-Cell Immunotherapy Market Share by Type
6.6.3 Asia-Pacific T-Cell Immunotherapy Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America T-Cell Immunotherapy Market Share by Type
6.7.3 South America T-Cell Immunotherapy Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa T-Cell Immunotherapy Market Share by Type
6.8.3 Middle East & Africa T-Cell Immunotherapy Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading T-Cell Immunotherapy Players
7.1 AbbVie
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Adaptimmune
7.3 Altor Bioscience
7.4 Amgen
7.5 Bluebird Bio
7.6 Celgene Corporation
7.7 Cellectis
7.8 DiaCarta
7.9 Fate Therapeutics
7.10 Gilead Sciences
7.11 Juno Therapeutics
7.12 Kite Pharma
7.13 Merck
7.14 Novartis
7.15 Pfizer
7.16 Sorrento Therapeutics
7.17 Takara Bio
7.18 TCR2 Therapeutics
7.19 Unum Therapeutics
Chapter 8 Upstream and Downstream Analysis of T-Cell Immunotherapy
8.1 Industrial Chain of T-Cell Immunotherapy
8.2 Upstream of T-Cell Immunotherapy
8.3 Downstream of T-Cell Immunotherapy
Chapter 9 Development Trend of T-Cell Immunotherapy (2022-2030)
9.1 Global T-Cell Immunotherapy Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure T-Cell Immunotherapy Example
Figure Global T-Cell Immunotherapy Revenue (Million $) Status and Outlook (2016-2030)
Figure Global T-Cell Immunotherapy Revenue (Million $) Comparison by Region (2016-2030)
Figure Global T-Cell Immunotherapy Revenue (Million $) Comparison by Type (2016-2030)
Figure Global T-Cell Immunotherapy Revenue (Million $) Comparison by Application (2016-2030)
Figure Global T-Cell Immunotherapy Revenue (Million $) Comparison by Sales Channel (2016-2030)
Table Global T-Cell Immunotherapy Sales by Player (2019-2021)
Table Global T-Cell Immunotherapy Sales Market Share by Player (2019-2021)
Figure Global T-Cell Immunotherapy Sales Market Share by Player in 2021
Table Global T-Cell Immunotherapy Revenue (Million $) by Player (2019-2021)
Table Global T-Cell Immunotherapy Revenue Market Share by Player (2019-2021)
Figure Global T-Cell Immunotherapy Revenue Market Share by Player in 2021
Table Global T-Cell Immunotherapy Average Price by Player (2019-2021)
Figure Global T-Cell Immunotherapy Average Price by Player in 2021
Figure Global T-Cell Immunotherapy Players Competition Situation Top 5 Players Revenue Market Share in 2019
Figure Global T-Cell Immunotherapy Players Competition Trends Top 5 Players Revenue Market Share in 2021
Figure Example of CAR-T
Figure Global CAR-T Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of TCR
Figure Global TCR Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of TIL Therapies
Figure Global TIL Therapies Revenue (Million $) and Growth Rate (2016-2021)
Table Global T-Cell Immunotherapy Sales by Type (2016-2021)
Table Global T-Cell Immunotherapy Sales Market Share by Type (2016-2021)
Figure Global T-Cell Immunotherapy Sales Market Share by Type in 2021
Table Global T-Cell Immunotherapy Revenue (Million $) by Type (2016-2021)
Table Global T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
Figure Global T-Cell Immunotherapy Revenue Market Share by Type in 2021
Table Global T-Cell Immunotherapy Average Price by Type (2016-2021)
Figure Global T-Cell Immunotherapy Average Price by Type in 2021
Table Leading Players of T-Cell Immunotherapy by Type in 2021
Figure Example of Hematologic Malignancies
Figure Global T-Cell Immunotherapy for Hematologic Malignancies Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Solid Tumors
Figure Global T-Cell Immunotherapy for Solid Tumors Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Others
Figure Global T-Cell Immunotherapy for Others Revenue (Million $) and Growth Rate (2016-2021)
Table Global T-Cell Immunotherapy Sales by Application (2016-2021)
Table Global T-Cell Immunotherapy Sales Market Share by Application (2016-2021)
Figure Global T-Cell Immunotherapy Sales Market Share by Application in 2021
Table Leading Consumers of T-Cell Immunotherapy by Application in 2021
Figure Example of Direct Channel
Figure Global T-Cell Immunotherapy for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Distribution Channel
Figure Global T-Cell Immunotherapy for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)
Table Global T-Cell Immunotherapy Revenue by Sales Channel (2016-2021)
Table Global T-Cell Immunotherapy Revenue Market Share by Sales Channel (2016-2021)
Figure Global T-Cell Immunotherapy Revenue Market Share by Sales Channel in 2021
Table Leading Distributors/Dealers of T-Cell Immunotherapy by Sales Channel in 2021
Table Global T-Cell Immunotherapy Market Size and CAGR by Region (2016-2030)
Table Global T-Cell Immunotherapy Sales by Region (2016-2021)
Table Global T-Cell Immunotherapy Sales Market Share by Region (2016-2021)
Figure Global T-Cell Immunotherapy Sales Market Share by Region in 2021
Table Global T-Cell Immunotherapy Revenue (Million $) by Region (2016-2021)
Table Global T-Cell Immunotherapy Revenue Market Share by Region (2016-2021)
Figure Global T-Cell Immunotherapy Revenue Market Share by Region in 2021
Table North America T-Cell Immunotherapy Sales by Country (2016-2021)
Figure North America T-Cell Immunotherapy Sales Market Share by Country (2016-2021)
Table North America T-Cell Immunotherapy Revenue by Country (2016-2021)
Figure North America T-Cell Immunotherapy Revenue Market Share by Country (2016-2021)
Figure North America T-Cell Immunotherapy Market Share by Type in 2021
Figure North America T-Cell Immunotherapy Market Share by Application in 2021
Figure United States T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure United States T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Canada T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Canada T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Mexico T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Mexico T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Table Europe T-Cell Immunotherapy Sales by Country (2016-2021)
Figure Europe T-Cell Immunotherapy Sales Market Share by Country (2016-2021)
Table Europe T-Cell Immunotherapy Revenue by Country (2016-2021)
Figure Europe T-Cell Immunotherapy Revenue Market Share by Country (2016-2021)
Figure Europe T-Cell Immunotherapy Market Share by Type in 2021
Figure Europe T-Cell Immunotherapy Market Share by Application in 2021
Figure Germany T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Germany T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure UK T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure UK T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure France T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure France T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Italy T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Italy T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Russia T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Russia T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Spain T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Spain T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Table Asia-Pacific T-Cell Immunotherapy Sales by Country (2016-2021)
Figure Asia-Pacific T-Cell Immunotherapy Sales Market Share by Country (2016-2021)
Table Asia-Pacific T-Cell Immunotherapy Revenue by Country (2016-2021)
Figure Asia-Pacific T-Cell Immunotherapy Revenue Market Share by Country (2016-2021)
Figure Asia-Pacific T-Cell Immunotherapy Market Share by Type in 2021
Figure Asia-Pacific T-Cell Immunotherapy Market Share by Application in 2021
Figure China T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure China T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Japan T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Japan T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Korea T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Korea T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure India T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure India T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Southeast Asia T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Southeast Asia T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Australia T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Australia T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Table South America T-Cell Immunotherapy Sales by Country (2016-2021)
Figure South America T-Cell Immunotherapy Sales Market Share by Country (2016-2021)
Table South America T-Cell Immunotherapy Revenue by Country (2016-2021)
Figure South America T-Cell Immunotherapy Revenue Market Share by Country (2016-2021)
Figure South America T-Cell Immunotherapy Market Share by Type in 2021
Figure South America T-Cell Immunotherapy Market Share by Application in 2021
Figure Brazil T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Brazil T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Argentina T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Argentina T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Colombia T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Colombia T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Table Middle East & Africa T-Cell Immunotherapy Sales by Country (2016-2021)
Figure Middle East & Africa T-Cell Immunotherapy Sales Market Share by Country (2016-2021)
Table Middle East & Africa T-Cell Immunotherapy Revenue by Country (2016-2021)
Figure Middle East & Africa T-Cell Immunotherapy Revenue Market Share by Country (2016-2021)
Figure Middle East & Africa T-Cell Immunotherapy Market Share by Type in 2021
Figure Middle East & Africa T-Cell Immunotherapy Market Share by Application in 2021
Figure UAE T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure UAE T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Saudi Arabia T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure Saudi Arabia T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Figure South Africa T-Cell Immunotherapy Sales and Growth Rate (2016-2021)
Figure South Africa T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2016-2021)
Table Company Snapshot of AbbVie
Table T-Cell Immunotherapy Introduction of AbbVie
Table T-Cell Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share of AbbVie (2019-2021)
Table Industrial Chain of T-Cell Immunotherapy
Table Manufacturing Cost Structure of T-Cell Immunotherapy
Table General Manufacturing Process of T-Cell Immunotherapy
Table Leading Distributors/Dealers of T-Cell Immunotherapy
Table Leading Consumers of T-Cell Immunotherapy
Figure Global T-Cell Immunotherapy Sales and Growth Rate Forecast (2022-2030)
Figure Global T-Cell Immunotherapy Revenue and Growth Rate Forecast (2022-2030)
Table Global T-Cell Immunotherapy Market Size and CAGR Forecast by Region (2022-2030)
Table Global T-Cell Immunotherapy Market Size and CAGR Forecast by Type (2022-2030)
Table Global T-Cell Immunotherapy Market Size and CAGR Forecast by Application (2022-2030)
Table Global T-Cell Immunotherapy Market Size and CAGR Forecast by Sales Channel (2022-2030)
Buy
